Jason V Coloma Net Worth

What's Jason Coloma's mailing address?

Jason's mailing address filed with the SEC is C/O CORVUS PHARMACEUTICALS, INC., 863 MITTEN ROAD, SUITE 102, BURLINGAME, CA, 94010.

Insiders trading at Corvus Pharmaceuticals Inc

Over the last 9 years, insiders at Corvus Pharmaceuticals Inc have traded over $52,808,904 worth of Corvus Pharmaceuticals Inc stock and bought 11,523,300 units worth $85,214,510 . The most active insiders traders include Holdings A/S Novo, Street Partners Llc Adams, and Capital, Llc Eco R1. On average, Corvus Pharmaceuticals Inc executives and independent directors trade stock every 46 days with the average trade being worth of $1,530,854. The most recent stock trade was executed by William Benton Jones on 6 May 2024, trading 20,000 units of CRVS stock currently worth $34,600.

What does Corvus Pharmaceuticals Inc do?

corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.

Corvus Pharmaceuticals Inc executives and stock owners

Corvus Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Daniel Hunt,
  Senior Vice President, Chief Business Officer
• Mehrdad Mobasher,
  Vice President, Chief Medical Officer
• Richard Miller,
  Chairman of the Board, President, Chief Executive Officer
• Leiv Lea,
  Chief Financial Officer
• Dr. Mehrdad Mobasher M.D., M.P.H.,
  Sr. VP & Chief Medical Officer
• Leiv Lea,
  Chief Financial Officer
• Steve Krognes,
  Independent Director
• Peter Thompson,
  Independent Director
• Elisha Gould,
  Independent Director
• Dr. Richard A. Miller M.D.,
  Co-Founder, Pres, CEO & Chairman
• Scott Morrison,
  Independent Director
• Dr. Peter A. Thompson FACP, M.D.,
  Co-Founder & Independent Director
• Linda Grais,
  Independent Director
• Ian Clark,
  Independent Director
• Edith Mitchell,
  Director
• Erik Verner,
  Vice President of Chemistry Research
• William Jones,
  Senior Vice President of Pharmaceutical Development
• Dr. James T. Rosenbaum M.D.,
  Sr. VP of Research
• Dr. Erik J. Verner Ph.D.,
  Co-Founder
• Stephen Willingham,
  Sr. Scientist
• Alan C. Mendelson Esq.,
  Sec.
• Dr. Long Kwei Ph.D.,
  Sr. VP of Biometrics
• Dr. William Benton Jones,
  Sr. VP of Pharmaceutical Devel.
• Debra Horen SPHR,
  VP of HR
• Street Partners Llc Adams,
  10% owner
• Advisors Llc Orbi Med Capit...,
  
• Jason V Coloma,
  SVP, Chief Business Officer
• Holdings A/S Novo,
  10% owner
• Advisors Llc Orbimed,
  Director
• Terry P Gould,
  
• Joseph J Buggy,
  EVP, Discovery Research
• Advisors Llc Orbi Med Capit...,
  
• Capital, Llc Eco R1,
  10% owner
• Jeffrey Arcara,
  Chief Business Officer